PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 99 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q4 2014. The put-call ratio across all filers is 3.13 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $46,000 | +64.3% | 73,500 | +17.0% | 0.02% | +30.8% |
| Q2 2016 | $28,000 | -97.8% | 62,800 | -85.5% | 0.01% | -97.9% |
| Q4 2015 | $1,281,000 | -63.4% | 434,300 | -60.8% | 0.61% | -69.8% |
| Q3 2015 | $3,504,000 | -6.4% | 1,108,719 | +216.8% | 2.03% | -35.6% |
| Q1 2015 | $3,742,000 | -34.0% | 350,000 | -42.1% | 3.15% | -17.8% |
| Q4 2014 | $5,672,000 | – | 604,075 | – | 3.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 2,010,000 | $905,000 | 0.21% |
| GLOBEFLEX CAPITAL L P | 226,959 | $102,000 | 0.03% |
| ACUTA CAPITAL PARTNERS, LLC | 62,800 | $28,000 | 0.01% |
| MENTA CAPITAL LLC | 195,136 | $87,000 | 0.01% |
| Orbimed Advisors | 1,073,000 | $481,000 | 0.01% |
| GOODWIN DANIEL L | 22,679 | $10,000 | 0.00% |
| TUDOR INVESTMENT CORP ET AL | 215,800 | $97,000 | 0.00% |
| Renaissance Technologies | 2,214,396 | $992,000 | 0.00% |
| STOCK YARDS BANK & TRUST CO | 30,170 | $14,000 | 0.00% |
| HIGHLAND CAPITAL MANAGEMENT, LLC | 41,000 | $18,000 | 0.00% |